Regulatory Pathway for Drug-Device Combination Products in US

Authors

  • David R. Savello NDA Partners LLC, Rochelle, VA, USA

DOI:

https://doi.org/10.33892/aph.2021.91.135-137

Keywords:

Device, human factors, combination product, compliance, FDA guidance

Published

2021-11-15

How to Cite

(1)
Savello, D. R. Regulatory Pathway for Drug-Device Combination Products in US. Acta Pharm Hung 2021, 91, 135-137.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License